*The entire unedited article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.
For Q319, according to SmartTRAK’s Financial Dashboard, WW Advanced Wound Care (AWC) revenue for Advanced Dressings, External Devices and Biologics was up +5.9% YoY.
Acelity remained the WW AWC market leader, up +6.3% YoY, driven by Prevena and the Crawford acquisition. WW Advanced Dressings saw several strong shifts in the ranking of companies, with ConvaTec moving up to the 2nd position, surpassing Smith + Nephew (S+N), after ConvaTec recovering, but S+N facing continued declining growth. Mölnlycke led the market and Coloplast was the strongest growing of the top four. The total market was up +3.2% YoY. US Skin/Dermal Substitute (CTP) revenue increased, with xenografts, especially Organogenesis’ PuraPly, driving gains. WW NPWT was up +8.2% YoY, with traditional devices up +3.4% and single-use...Among the many topics covered in the complete, comprehensive Q319 Advanced Wound Care Market Recap* are:
The US Wound Biologics market, comprising the vast majority of the global biologics market includes the very competitive Cellular and/or Tissue-Based Products (CTPs or skin/dermal substitutes), the Topical Drug/Delivery category and Collagen Dressings. For Q319, the US market reached $
Read the complete, comprehensive Q319 Advanced Wound Care Market Recap including news, financial data, charts, company revenues and shares, plus insightful analysis from our team of experts*...
*The entire unedited article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.